Phase III Clinical Study of Valbenazine for Chorea in Huntington Disease

Phase III Clinical Study of Valbenazine for Chorea in Huntington Disease

Huntington Study Group Announces Initiation of Phase III Clinical Study of Valbenazine for the Treatment of Chorea Associated with Huntington Disease. - November 14, 2019 - Huntington Study Group

ALPCO Launches Analytically Specific Human and Rodent STELLUX® Glucagon ELISA

ALPCO Launches Analytically Specific Human and Rodent STELLUX® Glucagon ELISA

ALPCO's new STELLUX® Chemiluminescence Glucagon ELISA features increased analytical specificity and a broad range to accurately quantify glucagon levels between 0.86 and 143.7 pmol/L (3-500 pg/mL) in human and rodent samples. - November 06, 2019 - ALPCO

Compliance Resources from Nationwide Testing Association, Inc.

Compliance Resources from Nationwide Testing Association, Inc.

Nationwide Testing Association, Inc. recently launched a new resource center online. The resource center is aimed at keeping clients up-to-date on all things compliance. In Nationwide Testing Association, Inc.'s resource center, you will find training videos, and news releases on current industry topics. - November 05, 2019 - Nationwide Testing Association Inc.

ALPCO’s New Fecal Calprotectin ELISA with Superior Clinical Accuracy Receives FDA 510(k) Clearance

ALPCO’s New Fecal Calprotectin ELISA with Superior Clinical Accuracy Receives FDA 510(k) Clearance

ALPCO received 510(k) clearance from the US FDA for its new fecal Calprotectin Chemiluminescence ELISA test. The ALPCO Calprotectin Chemiluminescence ELISA’s superior clinical accuracy will enable clinical laboratories to provide the most accurate results to gastroenterologists facing the challenges of differentiating IBD from IBS. - October 30, 2019 - ALPCO

Cayman Awarded 1.5 Million Dollar SBIR Grant

The NIH’s National Institute of Arthritis and Musculoskeletal & Skin Diseases (NIAMS) has awarded Cayman Chemical with a Phase II Small Business Innovation Research (SBIR) grant to develop its patented small molecule bone repair agent KMN-159. - September 25, 2019 - Cayman Chemical Company

Scintica Instrumentation and Aspect Imaging Announce Exclusive Agreement for Pre-Clinical MRI Imaging Products

Scintica Instrumentation Inc. is excited to announce its exclusive distribution agreement with Aspect Imaging for the M-Series(TM) MRI systems for scientific research. With more than 100 MRI installations worldwide, Aspect’s compact MRI systems are self-shielding, cryogen free and do not need... - September 18, 2019 - Scintica Instrumentation

Neurology Associates Updates Name to Embrace Its Neuroscience Roots, Comprehensive Expertise

All Processes, Data Stay the Same for Patients, Providers - September 14, 2019 - Neurology Associates

Cambridge Cider Social Invites You to Celebrate Autumn by Tasting Hard Ciders and Donuts at a Fun Outdoor Festival

Cambridge Cider Social Invites You to Celebrate Autumn by Tasting Hard Ciders and Donuts at a Fun Outdoor Festival

On October 24, 2019 join the ALS Therapy Development Institute in Cambridge for an outdoor celebration of autumn with hard cider, apple cider donuts, seasonal snacks, music, and fun – all in support of a great cause. - September 10, 2019 - ALS Therapy Development Institute

Paras Biopharmaceuticals Successfully Develops Cytofold StructQuant® Technology for Cytoplasmic Disulphide Formation, (for Active Folding) for Complex Therapeutic Protein

Paras Biopharmaceuticals Successfully Develops Cytofold StructQuant® Technology for Cytoplasmic Disulphide Formation, (for Active Folding) for Complex Therapeutic Protein

Paras Biopharmaceuticals Finland Oy is pleased to announce that its proprietary technology, Cytofold StructQuant®, is established for the high-level expression of homogeneously folded disulfide bond containing proteins in the cytoplasm of E. Coli. The technology offers all cost benefits of... - September 10, 2019 - Paras Biopharmaceuticals Finland Oy

Biosynthetic Technologies Inks Patent License Agreement with Cayman Chemical for the Global Pharmaceutical and R&D Markets

Biosynthetic Technologies (BT) today announced it has signed on with Cayman Chemical for the production and distribution of novel Estolide compounds for pharmaceutical testing applications. BT is excited to partner with Cayman Chemical to provide discovery and pre-clinical development services to... - September 05, 2019 - Cayman Chemical Company

The Pediatric Cancer Research Foundation to Host 3rd Annual Dine & Donate During Childhood Cancer Awareness Month

The Pediatric Cancer Research Foundation to host its annual fundraiser to benefit pediatric cancer research. - August 28, 2019 - Pediatric Cancer Research Foundation

Neurology Associates Earns MRI Certification from Intersocietal Accreditation Commission

The designation not only guarantees that Neurology Associates adheres to and complies with stringent MRI standards and practices, it also extends coverage to patients insured by Medicare. - August 25, 2019 - Neurology Associates

Zifo RnD Solutions and Scilligence Announce Strategic Partnership

Zifo RnD Solutions and Scilligence Corporation announce a strategic partnership that enables Zifo to provide System Integrations Solutions for Scilligence suite of integrated informatics solutions. The partnership will help clients to easily select, evaluate, and implement solutions that fit their... - August 18, 2019 - Zifo

New Research Benchmarks Clinical Investigator Satisfaction with Pharma Sponsors and Central Laboratories

8-year Study Tracks Central Lab Performance and Identifies Covance as Leading the Way in Clinical Investigator Satisfaction. - August 13, 2019 - Life Science Strategy Group, LLC

Dribble for the Cure Returns to St. John's University on Saturday, September 21, 2019

Dribble for the Cure at St. John's University to be held on Saturday, September 21, 2019. - August 08, 2019 - Pediatric Cancer Research Foundation

Advances in Medicine Cause New, Groundbreaking Drug by Quantum Genomics (QNNTF) to Help with Chronic Hypertension

Quantum Genomics are the creators of Firibastat, a first-in-class brain aminopeptidase inhibitor (BAPAI) that could potentially treat treatment-resistant hypertension by acting in the brain to interfere with the renin-angiotensin system. It is estimated that there are around 150 million people... - August 05, 2019 - Quantum Genomics

American Association of Anatomists Gets Refresh as American Association for Anatomy

The American Association of Anatomists, the professional home for educators, researchers, and allied health professionals working in the anatomical sciences, has a new name and fresh look. The newly-named American Association for Anatomy is a diverse, inclusive, integrated, and international community. The new identity showcases the holistic nature of the organization, a vibrant new brand, and messaging focused on connecting science, knowledge, careers, research, and those working in anatomy. - August 05, 2019 - American Association for Anatomy

Brewing a Cure 4 ALS Fundraiser Invites You to Enjoy Regional Beers and Wines While Fundraising for ALS Research

Brewing a Cure 4 ALS Fundraiser Invites You to Enjoy Regional Beers and Wines While Fundraising for ALS Research

On Saturday, August 10, 2019, the first-ever Brewing a Cure 4 ALS fundraiser will be held at Technology Square in Cambridge, MA. Brewing a Cure 4 ALS invites community members to enjoy craft beer, wine, music, and food with the goal of raising money for ALS research at the ALS Therapy Development... - July 31, 2019 - ALS Therapy Development Institute

On August 18, Wear Your Nerdiest Costume and Run for a Great Cause at the Race 4 Research 5K in Cambridge

On August 18, Wear Your Nerdiest Costume and Run for a Great Cause at the Race 4 Research 5K in Cambridge

On Sunday, August 18, the ALS Therapy Development Institute (ALS TDI) will host the annual Race 4 Research 5K and Walk in Technology Square, Cambridge. The event will feature a chip-timed nerdy 5K road race (costumes encouraged), a 4-mile ALS awareness walk and wheelchair ride along the Charles,... - July 26, 2019 - ALS Therapy Development Institute

Multiplex ELISAs Offer Powerful Profiling Capabilities

Cayman now offers multiplex immunoassay technology powered by Quansys Biosciences. This line of fully quantitative Q-Plex™ multiplex ELISAs and chemiluminescent Q-View™ imagers provides a highly sensitive means to simultaneously measure multiple markers using a single sample. - June 22, 2019 - Cayman Chemical Company

ASA: New Headquarters for the Company

Technology, sustainability, lean management are only a few of the guidelines followed when building the new company headquarters in Arcugnano. In the name of welfare and of the spirit of belonging, the new structure, which houses production and offices, has provided for the adoption of innovative solutions in space management and in the choice of furnishings. - June 21, 2019 - ASA srl

BraveHeart Wireless Announces FDA Clearance of the BraveHeart™ Life Sensor Cardiac Monitoring System

BraveHeart Wireless Announces FDA Clearance of the BraveHeart™ Life Sensor Cardiac Monitoring System

The BraveHeart™ Life Sensor Cardiac Monitoring system has been cleared for use in health care settings. The Life Sensor monitoring system securely captures patients’ heart rate and EKG data, and transmits the data to health care providers in real time. More than 28 million Americans diagnosed with heart disease may benefit - with this number growing each year. - June 20, 2019 - BraveHeart Wireless Inc.

Orangetheory Fitness and Augie’s Quest Collaboration Funds Innovative Research at the ALS Therapy Development

Orangetheory Fitness and Augie’s Quest Collaboration Funds Innovative Research at the ALS Therapy Development

This past May over 1,100 members of Orangetheory Fitness ran, rowed, and lifted, earning “splat points,” which they turned into $4.5 million in donations for Augie’s Quest to Cure ALS. With this donation Augie’s Quest is supporting non-profit biotech, the ALS Therapy Development Institute (ALS TDI), to fast track cure-driven drugs for ALS. - June 20, 2019 - ALS Therapy Development Institute

New Research Benchmarks Pharma’s Changing Utilization of Real-World Evidence (RWE) and Its Impact on Contract Research Organizations (CROs)

Study Tracks Utilization of Real-World Data (RWD), Real-World Evidence (RWE) and Supportive Services and Implications to CROs. - June 11, 2019 - Life Science Strategy Group, LLC

Trek Across Country Raises Awareness of Childhood Cancer

Thomas Curran Walks to Raise $20,000 for Pediatric Cancer Research Foundation - June 09, 2019 - Pediatric Cancer Research Foundation

Health Choice PPO Selects Synergy Laboratories to Deliver High Quality, Cost-Effective Results

Health Choice PPO Selects Synergy Laboratories to Deliver High Quality, Cost-Effective Results

Health Choice PPO and Synergy Laboratories, two of Alabama’s leading healthcare companies have come together to provide the highest quality laboratory results to the physicians, hospitals and other medical professionals serving members of the Health Choice PPO network. - June 05, 2019 - Synergy Laboratories

Matreya, LLC is Now a Part of Cayman Chemical Company to Better Serve the Lipid Community

Cayman Chemical, an industry-leading supplier of bioactive lipids, analytical standards, and contract lipidomic services, announced today that it has acquired Matreya, LLC, a lipid biochemical company located in State College, Pennsylvania, with strengths in synthesis, extraction, and purification of natural products. Matreya stocks a wide selection of high-purity sphingolipids, phospholipids, fatty acids and esters, and sterols to be used as research standards. - June 05, 2019 - Cayman Chemical Company

University of Waterloo’s Kimia Lab and Huron Digital Pathology to Participate in $126M Industry Consortium Led by Sunnybrook Research Institute

University of Waterloo’s Kimia Lab and Huron Digital Pathology to Participate in $126M Industry Consortium Led by Sunnybrook Research Institute

The Canadian government, through its Strategic Innovation Fund, will invest up to $49 million to support the initiative, which, in addition to Kimia Lab and Huron Digital Pathology, consists of more than 70 partners from industry, academia, government organizations and not-for-profits. The consortium’s mandate is to accelerate the application of artificial intelligence and machine learning technologies to deliver better health outcomes, faster diagnoses and safer treatments. - June 03, 2019 - Kimia Lab, University of Waterloo

Plant-Based Weight Loss Pill Calocurb Rapidly Expands Globally

Plant-Based Weight Loss Pill Calocurb Rapidly Expands Globally

The ground-breaking plant-based dietary supplement calocurb™ is rapidly expanding internationally. Last week Iceland joined the list of countries that the supplement is now available in, which includes the United States, China and New Zealand. According to calocurb’s maker –... - May 31, 2019 - Calocurb

Pediatric Cancer Research Foundation to Host 26th Annual Western Roundup Event for Oncology Kids and Their Families

The Pediatric Cancer Research Foundation (PCRF) prepares to kick off the summer with its annual Western Roundup on Sunday, June 9th. - May 29, 2019 - Pediatric Cancer Research Foundation

Pillar Clinical Research Announces New Ratings Initiative: Pillar Precision

Pillar Clinical Research Announces New Ratings Initiative: Pillar Precision

The Dallas based research company plans to roll out a new clinical rating training program, Pillar Precision. The program includes a clinician guide featuring best practices for specific CNS indications, placebo response training, malingering detection, data-driven decision making, and multi-site... - May 24, 2019 - Pillar Clinical Research

Apostle Inc. Completes Series A Financing Led by ShangBay Capital

Apostle Inc. is pleased to announce the completion of its series A financing, raising $3.3 million. The investment round is led by ShangBay Capital, a Silicon Valley-based venture capital firm, focused on investing in early stage medical device and biotech companies. Three other Silicon... - May 24, 2019 - Apostle Inc

First Responders Unite to Arrest and Extinguish ALS

First Responders Unite to Arrest and Extinguish ALS

Inaugural Arrest and Extinguish event at Tanglewood raises over $50,000 for ALS research. - May 23, 2019 - ALS Therapy Development Institute

ReproTech Nevada Participates in Fundraising Event to Support Women with Cancer

ReproTech, Ltd., a cryobank specializing in long-term storage of human reproductive tissue (sperm, eggs, embryos and ovarian and testicular tissue), was proud to sponsor the entire staff of the ReproTech Nevada office who participated in Moms on the Run, a fitness organization that raises money to... - May 19, 2019 - ReproTech, LLC

First Responders Unite to End ALS at Inaugural Arrest & Extinguish Event

On May 18th, first responders will unite for a tug-of-war event at Tanglewood to raise money for ALS research. - May 11, 2019 - ALS Therapy Development Institute

Scientists at AbboMax Developed Antibodies Against PINK1 and Parkin to Study Parkinson’s Disease

A panel of PINK1 and Parkin antibodies was developed at Abbomax to investigate Parkinson’s disease (PD). These phosphospecific and paired antibodies would be useful tools for studies of PINK/Parkin pathways and signaling in PD. AbboMax has been developing & manufacturing high performance immunoassay reagents for many years in California. AbboMax specializes in high-quality custom service and products focusing on antibody and assay development. - May 09, 2019 - AbboMax, Inc.

Reuters to Make Documentary on Paras Biopharmaceuticals Finland Oy – Innovations in Biologics: Insights of a Leading Expert

Reuters to Make Documentary on Paras Biopharmaceuticals Finland Oy – Innovations in Biologics: Insights of a Leading Expert

Paras Biopharmaceuticals Finland Oy is proud to announce that Reuters.com / Reuters Plus has selected the Finland-based company, working on biologics manufacturing & innovations in the healthcare segment as a valued contributor to the future of healthcare solutions. The documentary is part of... - May 07, 2019 - Paras Biopharmaceuticals Finland Oy

May is ALS Awareness Month - #AskMeAboutALS

May is ALS Awareness Month. The ALS Therapy Development Institute is inviting the general public to participate, and hoping to inspire a larger dialogue around ALS, through #AskMeAboutALS. - May 01, 2019 - ALS Therapy Development Institute

Texas Clinical Research Company Announces Expansion and New Quality Assurance Initiative

Texas Clinical Research Company Announces Expansion and New Quality Assurance Initiative

Pillar Clinical Research (Pillar), with a focus on early and late stage CNS drug development, opens two new US research facilities in Illinois and Arkansas and adds Director of Quality Assurance. Dr. Andrew Kim joined the Chicago team in September of 2018, and has spent over 5 years in clinical... - April 18, 2019 - Pillar Clinical Research

Zifo RnD Solutions Announces Launch of Sci-Desk

Zifo RnD Solutions announced the launch of its latest product Sci-Desk, an on-demand, cloud-based, Scientific Application Support-in-a-box. Sci-Desk offers comprehensive managed services for Scientific & lab computing systems spanning Discovery, R&D and Manufacturing industries. “Sci-Desk is a first of its kind in the Life Science R&D Spectrum. Sci-Desk brings on-demand, scalable, customizable and secure support to scientific applications,” said Raj Prakash, CEO/Co-Founder of Zifo RnD Solutions. - April 18, 2019 - Zifo

Mother’s Day Weekend Meso Run Becomes an Annual Event to Help Fight Mesothelioma

The second Annual Mother’s Day Weekend Meso Run/Walk 5K will be on May 11 in Griffith Park’s Old Zoo and aims to raise awareness of and funds for research on mesothelioma. - April 12, 2019 - Mother's Day Meso Run

NY Radiation Specialists Unveils State-of-the-Art Linear Accelerator at NYCBS

NY Radiation Specialists Unveils State-of-the-Art Linear Accelerator at NYCBS

On Tuesday, March 25, New York Radiation Specialists unveiled its brand new Varian Halcyon Linear Accelerator, at New York Cancer & Blood Specialists’ Eastchester Center for Cancer Care. The “NYCBS” Eastchester location is a multi-lingual facility located at 2330 Eastchester... - April 08, 2019 - New York Radiation Specialists

Pediatric Cancer Research Foundation Receives Record Number of Scholarship Applications

Pediatric Cancer Research Foundation receives 100 applications from pediatric cancer survivors pursuing their education. - April 04, 2019 - Pediatric Cancer Research Foundation

NCHS Ramona Opens New Community Health Center

NCHS Ramona Opens New Community Health Center

North County Health Services Opens New Health Clinic in Ramona. - April 02, 2019 - NCHS

Are Antioxidants the Solution to Burning and Itchy Eyes?

A recently published study in The Ocular Surface journal authored by Experimentica Ltd. in collaboration with researchers from Loyola University Chicago and the University of Missouri – Kansas City suggests that a topical antioxidant formulation can improve the pathological signs associated with dry-eye disease. - March 26, 2019 - Experimentica Ltd

Huntington Study Group Achieves 100th Credentialed Research Site Milestone

Huntington Study Group Achieves 100th Credentialed Research Site Milestone

The Huntington Study Group (HSG), a world leader in spearheading research and conducting clinical trials in Huntington disease (HD), is excited to announce that it has credentialed Inland Northwest Research, LLC as the 100th HSG site in North America. “On behalf of myself and our site, I... - March 25, 2019 - Huntington Study Group

Pediatric Cancer Research Foundation’s Reaching for the Cure Raises Over $430,000

The Pediatric Cancer Research Foundation celebrates another successful event. - March 25, 2019 - Pediatric Cancer Research Foundation

Ted Baker to Host Grand Opening Event Benefiting Pediatric Cancer Research Foundation

A portion of sales from an exclusive March 14th evening event will benefit Pediatric Cancer Research Foundation (PCRF), funding research to improve the care, quality of life, and survival rate of children battling cancer. - March 15, 2019 - Pediatric Cancer Research Foundation

Pediatric Cancer Research Foundation's Reaching for the Cure Half Marathon, 10K, 5K Kids Run Returns to Irvine on Sunday, March 17, 2019

Pediatric Cancer Research Foundation to host its annual fundraiser to benefit pediatric cancer research. - March 15, 2019 - Pediatric Cancer Research Foundation

New Low-Height, Low-Frequency Vibration Isolation Platform Adapts to Space Constraints in Critical Micro- and Nano-Microscopy

New Low-Height, Low-Frequency Vibration Isolation Platform Adapts to Space Constraints in Critical Micro- and Nano-Microscopy

At just 2-1/4 inches in height, while isolating vibrations as low as 1 hertz, the new completely-passive Negative-Stiffness tabletop vibration isolation platform – developed by Minus K Technology – provides the industry’s thinnest low-height, low-frequency isolator for optimizing space in critical microscopy and laboratory applications. - March 14, 2019 - Minus K Technology Inc.

Press Releases 301 - 350 of 2,315